These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6193532)

  • 41. Complement and protease inhibitors in the mucocutaneous lymph node syndrome.
    Rieger CH; Kawasaki T; Yanase Y; Pollack U
    Eur J Pediatr; 1983 Apr; 140(2):92-7. PubMed ID: 6192994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies of protease inhibitors in the sera of patients with amyotrophic lateral sclerosis.
    Adachi N; Shoji S
    J Neurol Sci; 1989 Feb; 89(2-3):165-8. PubMed ID: 2466958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Partial primary structure of human alpha 2-antiplasmin-homology with other plasma protease inhibitors.
    Lijnen HR; Wiman B; Collen D
    Thromb Haemost; 1982 Dec; 48(3):311-4. PubMed ID: 6984543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.
    Rao AK; Schmaier AH; Colman RW
    Pathobiol Annu; 1982; 12():35-64. PubMed ID: 6186978
    [No Abstract]   [Full Text] [Related]  

  • 45. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunological studies of plasma protease inhibitors associated with human blood platelets.
    Endresen GK
    Thromb Res; 1980 Jul 1-15; 19(1-2):157-63. PubMed ID: 6160634
    [No Abstract]   [Full Text] [Related]  

  • 47. The study of local fibrinolysis in abortion.
    Ikeuchi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1215-23. PubMed ID: 2411832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levels of serum protease inhibitors during fetal and postnatal development of the pig.
    Weström BR; Karlsson BW; Svendsen J
    Biol Neonate; 1982; 41(1-2):22-31. PubMed ID: 6175350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A case report of hereditary angioedema and studies on the serum components of complement, C1-inactivator and proteinase inhibitors during edema attack].
    Mikami A; Kohno M
    Hokkaido Igaku Zasshi; 1987 May; 62(3):497-500. PubMed ID: 3610041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concentrations of alpha 1-proteinase inhibitor and alpha 2-macroglobulin in serum and lung secretions of intubated infants.
    Bruce MC; Martin RJ; Boat TF
    Pediatr Res; 1984 Jan; 18(1):35-40. PubMed ID: 6199725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protease inhibitors in porcine serum and their immunological relationships to human protease inhibitors.
    Weström BR
    Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1861-7. PubMed ID: 93563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndrome.
    Bergstein JM; Kuederli U; Bang NU
    Am J Med; 1982 Sep; 73(3):322-7. PubMed ID: 6181678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
    Travis J; Salvesen G
    Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
    Campo G; Modena N; Gallo A; Ciaffoni S
    Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The protease inhibitor potential in newborns with respiratory distress syndrome].
    Weissbach G; Domula M; Lenk H; Rogos R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):89-102. PubMed ID: 88394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].
    Matsuda T
    Rinsho Ketsueki; 1978 Jul; 19(7):947-54. PubMed ID: 81330
    [No Abstract]   [Full Text] [Related]  

  • 57. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
    Nielsen CH; Poulsen HK; Teisner B; Thorsen P; Hau J; Westergaard JG
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):63-71. PubMed ID: 7506680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional activities and nonenzymatic glycosylation of plasma proteinase inhibitors in diabetes.
    Hall P; Tryon E; Nikolai TF; Roberts RC
    Clin Chim Acta; 1986 Oct; 160(1):55-62. PubMed ID: 2429788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protease inhibitors in rheumatoid synovial fluid. Analyses of electrophoretic homogeneity and protease inhibitory capacity.
    Ekerot L; Ohlsson K
    Rheumatol Int; 1982; 2(1):21-6. PubMed ID: 6184771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitors of fibrinolysis in diabetic children, mothers, and their newborn.
    Ambrus CM; Ambrus JL; Courey N; Mosovich L; Bruck E; Allen J; Jung O; Mirand E; Niswander K
    Am J Hematol; 1979; 7(3):245-54. PubMed ID: 94976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.